Advanced glycation end products suppress neuropilin-1 expression in podocytes by a reduction in Sp1-dependent transcriptional activity

American Journal of Nephrology

Volumn 30, Issue 4, 2009, Pages 336-345

  Bondeva, Tzvetanka ^a   Wolf, Gunter ^a,b  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b Klinik für Innere Medizin III   (Germany)

Author keywords

Advanced glycation end products; Diabetic nephropathy; Neuropilin 1 promoter; Podocytes

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BOVINE SERUM ALBUMIN; NEUROPILIN 1; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP2;

ANIMAL CELL; ARTICLE; DNA SYNTHESIS INHIBITION; DOWN REGULATION; GENETIC TRANSCRIPTION; MOUSE; NONHUMAN; PODOCYTE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CELL LINE, TRANSFORMED; DIABETIC NEPHROPATHIES; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION; GLYCOSYLATION END PRODUCTS, ADVANCED; MICE; NEUROPILIN-1; PODOCYTES; POINT MUTATION; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; SERUM ALBUMIN, BOVINE; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 67649836794     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000227762     Document Type: Article

References (28)

1. Anderson RB, Jackson SC, Fujisawa H, Key B: Expression and putative role of neuropilin-1 in the early scaffold of axon tracts in embryonic xenopus brain. Dev Dyn 2000; 219: 102-108. (Pubitemid 30667129)
2. Fujisawa H: From the discovery of neuropilin to the determination of its adhesion sites. Adv Exp Med Biol 2002; 515: 1-12.
3. Pasterkamp RJ, De Winter F, Giger RJ, Verhaagen J: Role for semaphorin III and its receptor neuropilin-1 in neuronal regeneration and scar formation? Prog Brain Res 1998; 117: 151-170.
4. Nakamura F, Tanaka M, Takahashi T, Kalb RG, Strittmatter SM: Neuropilin-1 transcellular domains mediate semaphorin D/III-induced growth cone collapse. Neuron 1998; 21: 1093-1100. (Pubitemid 29018078)
5. Pan Q, Chathery Y, Wu Y, Rathore N, Tong RK, Peale F, Bagri A, Tessier-Lavigne M, Koch AW, Watts RJ: Neuropilin-1 binds to VEGF 121 and regulates endothelial cell migration and sprouting. J Biol Chem 2007; 282: 24049-24056. (Pubitemid 47328044)
6. Banerjee SK, Zoubine MN, Tran TM, Weston AP, Campbell DR: Overexpression of vascular endothelial growth factor 164 and its co-receptor neuropilin-1 in estrogen-induced rat pituitary tumors and GH3 rat pituitary tumor cells. Int J Oncol 2000; 16: 253-260.
7. Bondeva T, Ruster C, Franke S, Hammerschmid E, Klagsbrun M, Cohen CD, Wolf G: Advanced glycation end-products suppress neuropilin-1 expression in podocytes. Kidney Int 2009; 75: 605-616.
8. Fakhari M, Pullirsch D, Abraham D, Paya K, Hofbauer R, Holzfeind P, Hofmann M, Aharinejad S: Selective upregulation of vascular endothelial growth factor receptors neuropilin-1 and -2 in human neuroblastoma. Cancer 2002; 94: 258-263. (Pubitemid 34049067)
9. Corbel C, Lemarchandel V, Thomas-Vaslin V, Pelus AS, Agboton C, Romeo PH: Neuropilin 1 and CD25 co-regulation during early murine thymic differentiation. Dev Comp Immunol 2007; 31: 1082-1094. (Pubitemid 47588403)
10. Bourbie-Vaudaine S, Blanchard N, Hivroz C, Romeo PH: Dendritic cells can turn CD4+ T lymphocytes into vascular endothelial growth factor-carrying cells by intercellular neuropilin-1 transfer. J Immunol 2006; 177: 1460-1469. (Pubitemid 44092479)
11. Belaid Z, Hubint F, Humblet C, Boniver J, Nusgens B, Defresne MP: Differential expression of vascular endothelial growth factor and its receptors in hematopoietic and fatty bone marrow: evidence that neuropilin-1 is produced by fat cells. Haematologica 2005; 90: 400-401. (Pubitemid 40388990)
12. Guan F, Villegas G, Teichman J, Mundel P, Tufro A: Autocrine class 3 semaphorin system regulates slit diaphragm proteins and podocyte survival. Kidney Int 2006; 69: 1564-1569.
13. Shankland SJ, Pippin JW, Reiser J, Mundel P: Podocytes in culture: past, present, and future. Kidney Int 2007; 72: 26-36. (Pubitemid 47014453)
14. Rüster C, Bondeva T, Franke S, Forster M, Wolf G: Advanced glycation end-products induce cell cycle arrest and hypertrophy in podocytes. Nephrol Dial Transplant 2008; 23: 2179-2191. (Pubitemid 351957612)
15. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta c(t)) method. Methods 2001; 25: 402-408. (Pubitemid 34164012)
16. Rossignol M, Pouyssegur J, Klagsbrun M: Characterization of the neuropilin-1 promoter gene expression is mediated by the transcription factor Sp1. J Cell Biochem 2003; 88: 744-757. (Pubitemid 36258824)
17. Wolf G, Chen S, Ziyadeh FN: From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. Diabetes 2005; 54: 1626-1634. (Pubitemid 40770751)
18. Bohlender JM, Franke S, Stein G, Wolf G: Advanced glycation end products and the kidney. Am J Physiol Renal Physiol 2005; 289: F645-F659. (Pubitemid 41324185)
19. Wendt TM, Tanji N, Guo J, Kislinger TR, Qu W, Lu Y, Bucciarelli LG, Rong LL, Moser B, Markowitz GS, Stein G, Bierhaus A, Liliensiek B, Arnold B, Nawroth PP, Stern DM, D'Agati VD, Schmidt AM: RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy. Am J Pathol 2003; 162: 1123-1137. (Pubitemid 36350658)
20. Turk N, Mornar A, Mrzljak V, Turk Z: Urinary excretion of advanced glycation end-products in patients with type 2 diabetes and various stages of proteinuria. Diabetes Metab 2004; 30: 187-192. (Pubitemid 38715176)
21. Kriz W, Gretz N, Lemely KV: Progression of glomerular diseases: is the podocyte the culprit? Kidney Int 1998; 54: 687-697.
22. Kaczynski J, Cook T, Urrutia R: SpI- and Krüppel-like transcription factors. Genom Biol 2003; 4: 206.
23. Kininis M, Kraus WL: A global view of transcriptional regulation by nuclear receptors: gene expression, factor localization, and DNA sequence analysis. Nucl Rec Sign 2008; 6:e005.
24. Bierhaus A, Humpert PM, Morcos M, Wendt T, Chavakis T, Arnold B, Stern DM, Nawroth PP: Understanding RAGE, the receptor for advanced glycation end products. J Mol Med 2005; 83: 876-886. (Pubitemid 41598688)
25. SKP2 ubiquitin ligase and Src. J Biol Chem 2009; 284: 5265-5276.
26. Zhan Y, Brown C, Maynard E, Anshelevich A, Ni W, Ho I, Oettgen P: Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling. J Clin Invest 2005; 115: 2508-2516. (Pubitemid 41266213)
27. Bondeva T, Roger T, Wolf G: Differential regulation of Toll-like receptor 4 gene expression in renal cells by angiotensin II: dependency on AP1 and PU.1 transcriptional sites. Am J Nephrol 2007; 27: 308-314. (Pubitemid 47164681)
28. Gurley SB, Coffman TM: The renin-angiotensin system and diabetic nephropathy. Semin Nephrol 2007; 27: 144-152.